Business Context and Reporting Period
This Form 6-K filing by Galmed Pharmaceuticals Ltd. covers the month of July 2026. The report serves to notify shareholders of the upcoming Annual General Meeting of Shareholders scheduled for August 26, 2026, at 4:00 p.m. Israel time.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a procedural notice regarding a shareholder meeting and does not contain financial statements or performance data.
Material Changes
No material changes to financial performance or operations are reported in this filing. The document focuses solely on corporate governance procedures.
Guidance, Outlook, and Risks
The filing does not contain management commentary, financial guidance, outlook, or specific risk factors. It references the attached Notice of the Annual General Meeting and Proxy Statement (Exhibit 99.1) for further details on the meeting agenda.
Key Facts for Investors
- Meeting Date: Annual General Meeting is set for Wednesday, August 26, 2026.
- Location: Meitar | Law Offices, 16 Abba Hillel Silver Rd., Ramat Gan, Israel.
- Documentation: The Notice of Meeting and Proxy Card are attached as Exhibits 99.1 and 99.2.
- Financial Data: No financial results are included in this specific filing.